Technical Analysis

SPARC (₹377.1): Sell

Yoganand D BL Research Bureau | Updated on May 15, 2018 Published on May 15, 2018

 Investors with a short-term view can sell the stock of Sun Pharma Advanced Research Company (SPARC) at current levels. Since encountering a key resistance at around ₹525 in early January, the stock has been in a medium-term downtrend.

While trending down, the stock breached a key support at ₹450 in early February and extended the fall. In April, the stock met with a key resistance at ₹430 and resumed its downtrend.



On Tuesday, the stock fell 3.2 per cent, breaching a key support at ₹400 as well as its 200-day moving average. The stock is trading well below its 50-DMA. Both the daily and weekly price rate of change indicators feature in the negative territory implying selling interest.

Overall, the short-term outlook is bearish for the stock. It can continue to decline and hit the price targets of ₹362 and ₹354 in the coming sessions. Sell with stop-loss at ₹385.

(Note: The recommendations are based on technical analysis. There is a risk of loss in trading.)

Read the rest of this article by Signing up for Portfolio.It's completely free!

What You'll Get

This article is closed for comments.
Please Email the Editor